Abstract-Objective: Rapid advances of high-throughput technologies and wide adoption of electronic health records (EHRs) have led to fast accumulation of -omic and EHR data. These voluminous complex data contain abundant information for precision medicine, and big data analytics can extract such knowledge to improve the quality of healthcare. Methods: In this paper, we present -omic and EHR data characteristics, associated challenges, and data analytics including data preprocessing, mining, and modeling. Results: To demonstrate how big data analytics enables precision medicine, we provide two case studies, including identifying disease biomarkers from multi-omic data and incorporating -omic information into EHR. Conclusion: Big data analytics is able to address -omic and EHR data challenges for paradigm shift toward precision medicine. Significance: Big data analytics makes sense of -omic and EHR data to improve healthcare outcome. It has long lasting societal impact.
system. The goal of the early "personalized medicine" model is to customize healthcare delivery for each individual and to maximize the effectiveness of each patient's treatment [1] . In 2009, Hood and Friend propose the "personalized, predictive, preventive, and participatory medicine" (a.k.a. P4 medicine) model that aims to transform current reactive care to future proactive medicine, and ultimately to reduce healthcare expenditure and improve patients' health outcome [2] . Recently, the new "precision medicine" model is proposed to precisely classify patients into subgroups sharing a common biological basis of diseases for more effective treatment and improved care outcome [3] , [4] . Precision medicine requires data utility ranging from collection and management (i.e., data storage, sharing, and privacy) to analytics (i.e., data mining, integration, and visualization) [5] . Because of rapid advances in biotechnologies, highly complex biomedical data are becoming available in huge volumes [6] . To make sense of these heterogeneous data, big data analytics, including data quality control, analysis, modeling, interpretation, and validation, is needed to cover application areas such as bioinformatics [7] [8] [9] , health informatics [10] [11] [12] , imaging informatics [13] , [14] , and sensor informatics [15] , [16] .
As presented in 2015 U.S. Precision Medicine Initiative [17] , incorporating -omic data and knowledge into electronic health record (EHR) (see Fig. 1 ) is viewed as a necessary step for delivering precision medicine [3] , [5] , [17] , [18] . Thus, this paper reviews big -omic and EHR data analytics for precision medicine with key terms summarized in Tables I and II . Section II presents -omic and EHR data characteristics, challenges, and big data analytics; Section III uses two case studies to illustrate the impact of big data analytics in precision medicine; Section IV enumerates several well-known biomedical big data initiatives; Section V discusses current opportunities in big data analytics for precision medicine; and finally, Section VI concludes this paper.
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[28] Fast Healthcare Interoperability Resources (FHIR) FHIR uses standardized "Resources" (i.e., predefined data formats and elements) to exchange EHR data. [29] II. BIG DATA FOR PRECISION MEDICINE The invention of high-throughput -omic assays such as nextgeneration sequencing (NGS) and mass spectrometry (MS) has led to fast accumulation of -omic data. Likewise, the wide adoption of EHR for the entire population provides a foundation for studying healthcare efficiency and safety [19] . -Omic data analytics often aims at finding biomarkers by cleaning up raw data generated by NGS or MS, extracting molecular profiles, identifying statistically significant molecules, constructing models describing molecular interactions or temporal system behavior, and validating putative biomarkers. EHR data analytics typically aims at predicting future outcome based on population and individual longitudinal data. The analytics has a similar process such as data cleaning, clinical features identification, predictive model construction, and clinical validation.
A. Biomedical Big Data
1) Big -Omic Data: -Omic data contain a comprehensive catalog of molecular profiles (e.g., genomic, transcriptomic, epigenomic, proteomic, and metabolomic as explained in Table II ) in biological samples that provide a basis for precision medicine [17] . The genome, transcriptome, and epigenome are upstream of the proteome and metabolome. A genome is unique and mostly invariant over time with its knowledge embedded in single nucleotide polymorphisms (SNPs), frameshift mutations (insertions or deletions; or indels), copy number variations (CNVs), and other structural variations (SVs) [30] , [31] ; transcriptomic knowledge is contained in gene expression, transcript expression, gene fusion, and alternative splicing [32] , [33] ; epigenomic knowledge is carried in protein-DNA binding sites, histone modification patterns, and DNA methylation patterns [34] ; proteomic knowledge is reflected by protein expression, posttranslational modification, and protein-protein interactions [35] ; and metabolomic knowledge is shown in the abundance of metabolites [36] . Because epigenomic information impacts transcriptomic, proteomic, and metabolomic profiles [37] , and the proteome and metabolome are directly responsible for the establishment of phenotypes, uncovering interactions among the proteome, metabolome, and upstream processes is a key toward precision medicine.
2) Big EHR Data: EHR data can be unstructured (e.g., clinical notes) or structured (e.g., ICD-9 diagnosis codes, administrative data, chart, and medication) [38] . Written or dictated clinical notes describe the patient's condition and are the most efficient and human-intuitive way for clinical documentation. However, they are the most challenging for computer analysis because of unstructured and heterogeneous data formats; abundant typing and spelling errors; violation of natural language grammar; and rich domain-specific abbreviations, acronyms, and idiosyncrasies [39] . Structured EHR data can be categorized into two classes [40] . Administrative data include those remain unchanged during the entire course of a clinical encounter (e.g., demographic data), and those keep updating over time (e.g., diagnoses and procedures) [41] . Ancillary clinical data are frequently recorded during a clinical encounter that can be discrete (e.g., physiological measures, medication, and lab tests), or continuous (e.g., respiration, blood pressure, pulse oximetry, and electrocardiography waveforms captured by sensors, either through bedside monitoring devices or ambulatory, implanted, or wearable devices) [40] .
B. Challenges Associated With -Omic and EHR Data
-Omic and EHR big data analytics is challenging due to data frequency, quality, dimensionality, and heterogeneity. 1) Diverse Data Collection Frequency: First, different data modalities have different data collection frequency. For example, in -omic data, a genome is invariant over a long period of time, and often only needs a one-time data acquisition, while other types of -omic data vary with environment, tissue types, and time that require multitime-point acquisition. In EHR, bedside monitoring data are captured at very high frequency, while lab tests may be taken a few times a day. In addition, data generation frequency may be influenced by cost (e.g., proteomic/metabolomic data generated by MS versus genomic/transcriptomic/epigenomic data generated by NGS). Second, data collection frequency can be irregular. For example, in EHR, most clinical variables have irregular sampling frequencies, depending on the criticality of a patient and the easiness of a measurement.
2) Inherent Data Quality Issues: In -omic data, quality issues are caused by a combination of biological, instrumental, and environmental factors such as sample contamination [42] , [43] , batch effects [44] , [45] , and low signal-to-noise ratios [46] , [47] . In EHR data, quality issues include missing data because recorded clinical variables vary with each clinical encounter and depend on clinical team's assessment of the patient's condition [48] , and erroneous data entries happening due to data entry mistakes or misinterpretation of original documents when entering [49] . For high-resolution waveform data, common quality issues include random noise, gaps in the waveform, and artifacts (e.g., patient's motion) [50] . These data quality issues may lead to wrong conclusion, but correcting these remains challenging.
3) High Dimensionality: A big challenge in either -omic or EHR data mining is the "curse of dimensionality" associated with high-dimensional data [51] . -Omic data often have many dimensions or features (may be more than 10 4 ) much larger than the number of samples available, while EHR data may contain a large sample size of high-dimensional data but with each individual sample only sparsely populated. Making sense of these data with statistical significance presents to be challenging.
4) Heterogeneous Data Types:
In -omics, using underlying molecular fingerprints to characterize disease subtypes may require heterogeneous multi-omic data. For example, the integrative personal omics profile project has integrated multiple molecular expression profiles to uncover dynamic molecular changes between healthy and diseased states [52] . However, integrating multi-omic data is challenging because of variations in represented biological processes, technical and biological noise levels, identification accuracy, spatiotemporal resolution, and many other confounding factors [53] . In EHR, the data are inherently heterogeneous. To accomplish precision medicine, it is necessary and critical to make sense of heterogeneous data.
C. Big Data Analytics for Precision Medicine

1) General Analytics for Biomedical Big Data:
Most -omic and EHR are high-dimensional data that not only require longer computational time but also affect the accuracy of analysis. Thus, we try to reduce data dimensionality by identifying a subset of variables or latent factors that preserve as much of the characteristics of the original data as possible with two strategies (see Table III ): 1) feature selection that aims to select an optimal subset of existing features; and 2) feature extraction that aims to transform existing features into a more compact set of dimensions [56] . Feature selection techniques consist of filtering, wrapper, or embedded methods. Filtering methods limit the number of features by calculating a score designed to estimate the usefulness of each feature. Thus, they are generally faster and do not require explicit class labeling. The minimum redundancy maximum relevance (mRMR) method is a filtering method that iteratively selects features sharing the most mutual information (relevance) with the least redundancy [57] . In contrast, wrapper methods select a subset of features (i.e., "wrap" the feature selection) for targeted learning models by using evaluation metrics such as cross-validation accuracy [58] . Embedded methods integrate machine learning algorithms [e.g., support vector machines (SVM)] with recursive feature elimination [59] .
Among feature extraction techniques, principal component analysis (PCA) is a basic method that identifies a small number of orthogonal linear vectors [51] . Its performance heavily depends on correctly identifying an optimal number of components, and requires careful testing and validation [60] . Other techniques include artificial neural networks such as autoencoders [61] , and nonlinear kernels in PCA [62] .
2) -Omic Data Preprocessing: NGS and MS highthroughput assays require different preprocessing methods that are summarized in Table IV . NGS is a popular assay for genomic, transcriptomic, and epigenomic studies. Its common preprocessing step is sequence mapping that identifies not only the origin but also the alignment of each read [78] . This step is computationally intensive and requires auxiliary data structures (e.g., the hash table [63] and the Burrows-Wheeler transform [64] ), multithreading, or in-memory computing [65] for improved computational efficiency. Genomic studies typically aim to identify variants in a sequenced genome [79] . Small-scale variant (i.e., SNPs and indels) detection uses "per base differences" between reads and the reference genome as the evidence [30] , [66] . Large-scale variant (i.e., SVs) detection uses readpair-based, read-depth-based, split-read-based, and assemblybased methods [80] , [81] . Transcriptomic studies mostly center on expression profiling, fusion gene detection, and alternative splicing detection [32] , [33] . Expression profiling associates mapped reads with genes and isoforms. Different profiling methods handle multimapped reads differently, where some methods associate the reads with all loci [67] , [68] , while others probabilistically associate the reads with only a few modelinferred loci [69] , [70] . Fusion gene detection relies on two factors, the spanning read pairs and the split read [24] , [25] . Alternative splicing detection relies on either de novo transcriptome assembly [71] , [72] , [82] [83] [84] , or inference from sequence mapping outputs [70] , [73] . Epigenomic studies mainly focus on identifying patterns of protein-DNA binding sites, histone modification, and DNA methylation [34] . Epigenomic data preprocessing builds a profile representing the density of reads along the genome, models background noises, and determines statistically significant peaks [78] . MS is for proteomic and metabolomic studies, and its preprocessing steps include alignment, baseline correction, and peak detection [85] . In chromatography-coupled MS, chromatographic peak alignment can correct drift to ensure coherent retention time and accurate mass across samples, and massto-charge ratio (m/z) alignment can ensure mass spectra and component features are comparable among samples [86] . In matrix-assisted laser desorption ionization (MALDI) MS, baseline correction is particularly important. Low-mass measurement noise from the chemical matrix used in MALDI experiments affects the spectral baseline and needs to be removed prior to analysis [87] . Peak detection is then performed based on criteria such as signal-to-noise ratio, peak shape, and detection thresholds [88] . A common subsequent step is the identification, and potentially the filtering, of isotopic peaks from the spectrum [77] .
3) Biomarker Identification Using -Omic Data: In practice, different groups of samples are collected for different * [95] omniBiomarker [96] DiffSplice [97] Differential alternative splicing MATS [98] DBChIP [99] Epigenomic Differential binding sites ChIPDiff [100] Differential histone modification sites QDMR [101] Differentially methylated regions DetectTLC [102] Proteomic and metabolomic Molecular patterns in mass spectrometry images Similarity scoring Automics [103] Differentially abundant metabolites Supervised and unsupervised learning MetaboAnalyst * [104] SNPassoc stands for SNP-based whole genome association studies; VAT, variant association tools; PLINK, population-based linkage analyses; edgeR, empirical analysis of digital gene expression data in R; MATS, multivariate analysis of transcript splicing; DBChIP, differential binding with ChIP-seq data; and QDMR, quantitative differentially methylated regions.
* Highly impactful tool with more than 50 citations per year.
biological conditions (e.g., disease vs. non-disease) or different time points (e.g., before vs. after a treatment). Thus, Table V summarizes selected tools that identify discriminatory biomarkers among different groups. Most -omic biomarkers are identified by investigating statistically significant differences among groups, such as differentially expressed genes or transcripts [94] [95] [96] , differential alternative splicing [97] , [98] , differential protein-DNA binding [99] , differential histone modification [100] , and differential DNA methylation [101] . The basic idea is to quantify and then fit the abundance of each group to Poisson-based distributions (e.g., the Poisson distribution and the negative binomial distribution), followed by statistical tests (e.g., the Fisher's exact test and the likelihood ratio test) that determine the statistical significance of each molecular feature. For genomic data, genome-wide association studies (GWAS) uses different approaches (e.g., the chi-squared test or logistic regression) to assess the degree of association between each variant and a targeted trait, and then select most significant variants as biomarkers [105] . Most GWAS focuses on SNP association [89] [90] [91] , while only a few infer CNV or SV association [92] , [93] .
4) Systems Biology Modeling Using -Omic Data:
To gain insights about a complex molecular system, we can conduct systems biology modeling using either "static network analysis" or "dynamic temporal analysis" based on -omic features (see Table VI ). Static network analysis studies the interactome (i.e., a complete set of molecular interactions) with three steps [113] : identifying a network scaffold that describes interactions among -omic features [106] , [108] , decomposing the network scaffold into smaller network modules [106] [107] [108] , and mathematically representing each network module for downstream simulation and analysis [114] . Most interactome networks use a single -omic data such as metabolic networks and gene regulatory networks. Few incorporate multi-omic data but are limited to simpler organisms (e.g., S. cerevisiae and C. elegans) [115] .
Dynamic temporal analysis (e.g., ordinary or partial differential equations, Boolean networks, agent-based models, and Petri nets [116] ) makes use of temporal measurement of -omic data to develop and validate dynamic predictive models of complex systems. For example, a recent study on A. thaliana used a Granger causality model to integrate two types of metabolomic data acquired at multiple time points for studying the interaction of primary and secondary metabolism [117] .
5) EHR Data Preprocessing:
Information embedded in EHR is abundant but disorganized in nature. Thus, EHR data requires systematic preprocessing that are summarized in Table VII . On EHR missing data, conventional approaches either impute missing values by the mean or median in a population, or listwise or pairwise delete records with missing values. These approaches are simple and easy to implement, but they ignore the underlying data structure and tend to introduce additional biases [128] . Thus, more robust missing data imputation methods such as interpolation [129] , multiple imputation [130] , expectation maximization [131] , and maximum likelihood [132] are needed.
On high time-resolution waveform data quality issues [50] , we can use the following: 1) filtering strategies such as median filtering, Kalman filtering, and model-based filtering to handle noise [50] , [123] ;
2) signal quality indices that detect the presence of expected physiological features, quantify the agreement between signals with mutual information, or infer other ad hoc definitions of signal quality to identify artifacts and gaps in the waveform [123] [124] [125] ;
3) sensor fusion techniques (e.g., using redundant measurements of electrocardiography, blood pressure sensors, and photoplethysmography to derive a more reliable measure of heart rate than any single signal alone [126] , [127] ) to correct artifacts and fill in gaps in the waveform.
6) EHR Data Mining:
To derive actionable knowledge from complex EHR big data, two strategies such as static endpoint prediction and temporal data mining are summarized in Table VIII. 6) a) Static endpoint prediction: After dimensionality reduction, we can model the relationship between selected clinical features (i.e., the patient's condition) and targeted clinical endpoints (i.e., the clinical outcome) with three groups of techniques: Regression analysis is a statistical process that estimates the relationship between independent variables (i.e., features) and dependent variables (i.e., endpoints). If dependent variables follow distributions such as normal, Poisson, and binomial, we can use a generalized linear model for regression model fitting; Classification involves building statistical models that assign a new observation to a known class. Many classification techniques such as decision trees, k-nearest neighbors, and SVMs prove to be effective in clinical applications; Associate Rule Learning (ARL) discovers frequent and reliable associations among clinical variables, and these association rules describe that if all elements in the antecedent occurs, all elements in the consequent should occur with certain confidence [28] . In general, these machine learning techniques prefer a large sample size.
6) b) Temporal data mining: EHR captures diagnosis, treatment, and outcome chronologically throughout a medical encounter, and thus, it is important to model temporal relationship between events using temporal data mining techniques such as the hidden Markov model (HMM) and the conditional random field (CRF) [135] , [136] . One constraint of HMM and CRF is that they require predefined clinical variables and outcome categories often difficult to generalize for a given treatment of a given patient. Thus, temporal association rule mining (TARM) is proposed to discover causality between the event and outcome. A temporal association rule, denoted by A → T C, describes an antecedent A followed by a consequent C separated by a time difference T. Because the selection of the event and outcome is flexible, the TARM model can be tailored for any event-outcome combination in various clinical settings [137] , [139] .
D. Enablers of Biomedical Big Data Analytics
The big data revolution has led to the development of enterprise tools and platforms for extracting, summarizing, and interpreting knowledge from rapidly generated data, for business intelligence, analytics, and predictive modeling as summarized in Table IX [11] , [140] , [141] .
Distributed computing systems such as Apache Hadoop (based on MapReduce) provide the storage and processing backbone for dealing with very large datasets [142] . Specific tools also exist to solve more specialized problems. For example, IBM InfoSphere Streams and Apache Spark Streaming can handle real-time streaming data [143] , [144] . Cloud computing providers such as Amazon Elastic Compute Cloud (EC2) can provide on-demand computing power to accommodate scalable growth from development to truly big data production [145] . Many cloud-based services in bioinformatics such as Illumina's BaseSpace [146] and the Galaxy project [147] are deployed on Amazon EC2. To deploy biomedical big data for precision medicine in health care, there is a critical need to address domain-specific challenges such as the requirements of Health Insurance Portability and Accountability Act, Health Information Technology for Economic and Clinical Health, and other privacy regulations. Thus, security is an important enabling technology (e.g., encryption for protected health information) in biomedical big data [140] , [145] , [148] .
III. CASE STUDIES
In this section, we present two real-world applications to illustrate the utility of biomedical big data analytics for precision medicine: 1) integrative -omic data for the improved understanding of cancer mechanisms (see Fig. 2) ; and 2) the incorporation of genomic knowledge into the EHR system for improved patient diagnosis and care (see Fig. 3 ).
A. Integrative -Omics for Precise Cancer Understanding
One notable effort that integrates multi-omic data for the improved understanding of cancer mechanisms is The Cancer Genome Atlas (TCGA) [149] . TCGA hosts public datasets of 27 cancer types with more than 11 000 patient cases. Each patient is annotated with clinical data (i.e., demographic, diagnostic, Fig. 3 . Integrating derived -omic knowledge into the existing EHR system is an approach to utilizing molecular information for clinical decision support, and it also help deliver precision medicine.
and survival data) and multimodal -omic data (i.e., genomic, transcriptomic, epigenomic, and proteomic).
We use head and neck squamous cell carcinoma (HNSCC) as an example to illustrate the integrative multi-omic study for precision medicine [150] . In 2014, a pan-cancer study with 12 cancer types using multi-omic TCGA data was performed [151] . Among 3527 samples in total, 305 were HNSCC. Six different data types (i.e., DNA copy number, methylation, mutation, and expression of mRNAs, miRNAs, and proteins) were analyzed both separately and integratively. By using clusteringbased methods, pathway activities (inferred from gene expression and copy number data) have shown common CNVs, mutation frequency patterns, and survival patterns between HN-SCC and lung squamous cell carcinomas or some bladder cancers. Such integrative pan-cancer analysis provides more precise subtyping across multiple cancers sharing common molecularlevel processes underlying cancer development. This new subtyping system reflects precision medicine because it finds precise classification of patients into disease subgroups.
TCGA Research Network has published more than 30 articles describing multi-omic investigation on numerous cancer types, and identified more precise, clinically relevant subtyping for multiple cancers [152] [153] [154] .
B. Adoption of Genomics in EHR for Precision Medicine
In a clinical setting, healthcare providers use electronic medical record (EMR) for clinical decision support. Thus, it is important to incorporate -omic data and knowledge into EMR. The Electronic Medical Records and Genomics (eMERGE) Network consortium aims to identify causal genomic variants (mostly SNPs) for EMR-based phenotypes and to integrate identified genotype-phenotype associations into the EMR system [155] . One crucial challenge is on how to store variants present in an individual or even in family members in the EMR [156] . The consortium has proposed several recommendations on augmenting the current EMR structure.
1) It should store various genomic variants, such as SNPs, indels, and CNVs, in a discrete computable format.
2) It needs to satisfy interoperability to reduce the burden in data transfer and update within and between healthcare facilities.
3) It has to support rule-based decision support engines.
4) It must contain abundant visualization elements for easier interpretation [157] .
Another big challenge is that each individual typically has millions of variants. The consortium has proposed one potential solution that stores only known pathological variants in the EMR system. However, because the set of known pathological variants may change over time, this approach may lead to the inclusion of false positive and the exclusion of false negative variants. Thus, an alternative solution is to archive raw data in separate repositories easily accessible when necessary [158] .
EMR is only for local clinic and hospital, while EHR contains and shares medical records among all participant clinics and hospitals [159] . Thus, interoperability is critical in using big data for precision medicine. Recently, the Health Level Seven International proposed the Fast Healthcare Interoperability Resources (FHIR) standard that addresses this important issue. On clinical genomics, several new FHIR resources and extension definitions are designed for variant data [160] . With such a standardized data exchange protocol, clinicians can utilize genomic information with other existing EHR data to determine the most effective treatment for each patient, which is a paradigm shift toward precision medicine.
IV. BIOMEDICAL BIG DATA INITIATIVES
To apply big data analytics for precision medicine, Table X summarizes multiple consortium initiatives that collect and organize data from various projects and trials, and make them available to the research community for secondary data use.
First, initiatives such as Project Data Sphere aim to improve research efficiency and to encourage collaboration by integrating information of clinical trials for different cancers. For example, the European Union-funded RD-Connect aggregates data of multiple rare diseases from around the world. TCGA of U.S., Therapeutically Applicable Research to Generate Effective Treatments, and the International Cancer Genome Consortium aim to study multiple aspects of individual diseases by collecting multi-omic data of hundreds of patients for each cancer type. In contrast, the U.S. 1000 Genomes Project and the U.K.-based 100 000 Genomes Project aim to connect genotypes with phenotypes using single -omic data type.
Second, large data repositories have been created and maintained by organizations such as U.S. National Institutes of Health (NIH) and the World Health Organization (WHO). The Trans-NIH BioMedical Informatics Coordinating Committee has established a data repository that archives the data from 61 large multicenter studies for promoting secondary use of biomedical data [161] . The Global Health Observatory Data Repository is maintained by WHO for population-level health studies [162] . As another example, the Health Indicators Warehouse within the U.S. Department of Health and Human Services provides country-level and state-level aggregated clinical information [163] .
V. DISCUSSION
Among many data types included in the NIH Big Data to Knowledge Initiative, -omic data, EHR, and medical imaging data are the three most important biomedical big data. We conducted the review of -omic and EHR data because of their close relationship with precision medicine [3] , [5] , [17] , [18] . Big data have had major societal impact in energy, environment, financial, and others. They motivate rapid advances in data storage, data mining and analytics, data retrieval, and data visualization [164] , [165] . When applying to biomedicine and healthcare, big data will improve quality and outcome by discovering new knowledge (e.g., automated identification of postoperative complications in EHR data [166] ); disseminating new knowledge (e.g., data-driven clinical decision support systems such as IBM Watson); incorporating -omic data into EHR (e.g., eMERGE network [167] ); and implementing patient-centered care (e.g., e-health [168] ).
To accelerate the delivery of precision medicine, more research is needed in the following biomedical big data areas.
1) -Omic data integration: As illustrated by the TCGA case study, integrative multi-omic data analysis is of growing importance because it provides holistic view of molecular fingerprints for each patient's condition. Recent research has shown positive impact of knowledge and insight obtained from integrative analysis of genomic and transcriptomic [169] , transcriptomic and proteomic [170] , and multiple -omic data types [53] , [151] on disease diagnosis, prognosis, and treatment. The next important direction is the development of guidelines (or best practices) for -omic data integration and interpretation that will in turn enable better prediction of biosystem behavior, and safer and more effective therapeutics.
2) Waveform and irregularly spaced time series analysis: Real-time streaming data analytics needs to be further developed due to the pervasive use of wearable sensors in either the critical care setting or in the continuous home monitoring setting for fitness and preventative medicine [171] , and the need to reduce alarm fatigue [172] . However, the challenge for irregularly sampled temporal data remains and requires advanced imputation techniques and robust parameter extraction techniques [50] , [173] .
3) Patient similarity: Precision medicine promotes precise subgroup classification of patients based on biological basis such as molecular profiles. Thus, EHR mining can assist in patient classification based on clinical measurements (e.g., drug responses, physiological signals, and disease susceptibility). However, because of high patient variability for any disease, the precise subtypes of many diseases remain unknown as of today, and it requires systematic big data analytics to model physician knowledge to validate the reliability of patient subgrouping based on EHR mining.
VI. CONCLUSION
In this review, we present -omic and EHR big data challenges and current progressed. We provide case studies to show how big data analytics can facilitate precision medicine. Because biomedical big data analytics is in its infancy, more biomedical data scientists and engineers are needed to gain necessary biomedical knowledge, to use large data provided by biomedical big data initiatives, and to put concerted effort in areas such as multi-omic data integration, waveform and time series data analysis, and patient similarity and so on to speed up big data research for precision medicine. By delivering the most suitable and effective treatment to each patient based on their precise subtyping information, the healthcare system can achieve better care efficiency and quality.
